#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ewing's sarcoma recurrent Astrocytoma Spinal muscular atrophy Pancreatic neuroendocrine tumour Prophylaxis against transplant rejection Idiopathic inflammatory myopathy Intracranial calcification Ventricular tachycardia Iron overload Duchenne muscular dystrophy gene carrier Chronic graft versus host disease in skin Enteritis Langerhans cell sarcoma Metastases to peritoneum Hereditary ataxia More trials…

    Learn about Rare Diseases

    Fragile X syndrome Prolymphocytic leukaemia – Trials in Disease Osteosarcoma recurrent – Trials in Disease Wiskott-Aldrich syndrome – Diagnostics Hypereosinophilic syndrome – Life with Disease Idiopathic inflammatory myopathy – Trials in Disease Stevens-Johnson syndrome – Diagnostics Adrenocortical carcinoma Progressive multifocal leukoencephalopathy Cystic fibrosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Givinostat Etanercept Iohexol Pf-06835375 Hyoscine Gsk3858279 Capecitabine Epinephrine Ethambutol Hydrochloride Flortaucipir (18F) Auto4 Ruxolitinib Pantothenate Sodium Elotuzumab Azd0901 Lufepirsen Cft1946 Vancomycin ABIRATERONE DECANOATE SELTOREXANT More therapies…

    Learn about Your Condition

    Mitochondrial DNA depletion Carotid artery occlusion Anal cancer metastatic Osteomyelitis HER2 protein overexpression Varicella Follicular lymphoma Malignant melanoma stage IV Fragile X syndrome Hodgkin's disease Dermatomyositis Cancer pain Retroperitoneal fibrosis Hypertrophic cardiomyopathy Microvillous inclusion disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Early Use of Risdiplam for Children with Spinal Muscular Atrophy After Gene Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Spinal muscular atrophy
    Investigated Drugs:
    • Risdiplam
    Germany Poland

  • Study on the Safety and Effectiveness of Rebisufligene Etisparvovec for Patients with Mucopolysaccharidosis Type IIIA

    Recruiting

    2 1 1
    Investigated Drugs:
    • Rebisufligene Etisparvovec
    Spain

  • Long-term safety study of rebisufligene etisparvovec gene therapy in patients previously treated for Mucopolysaccharidosis type IIIA

    Recruiting

    3 1 1
    Investigated Diseases:
    • Mucopolysaccharidosis III
    Investigated Drugs:
    • Rebisufligene Etisparvovec
    Spain

  • Study on the Safety and Tolerability of Treprostinil Sodium for Children with Pulmonary Arterial Hypertension

    Recruiting

    3 1 1
    Investigated Drugs:
    • Treprostinil Sodium
    Austria France Germany Hungary Slovakia Spain

  • Long-Term Follow-Up Study for Patients Treated with CAR T-Cell Therapy Using PHE885, YTB323, and Tisagenlecleucel

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • B-cell type acute leukaemia
    • Plasma cell myeloma
    Investigated Drugs:
    • Autologous T-Cells Encoding A Chimeric Antigen Receptor Targeting Human B Cell Maturation Antigen
    • Rapcabtagene Autoleucel
    • Tisagenlecleucel
    Austria Belgium Denmark Finland France Germany +6

  • Study on Bevacizumab, Encorafenib, and Cetuximab for Patients with BRAF-V600E Mutated Metastatic Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Encorafenib
    • Bevacizumab
    • Cetuximab
    Spain
Previous Page
1 … 434 435 436 437 438 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!